<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Transplant.</journal-id>
<journal-title>Frontiers in Transplantation</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Transplant.</abbrev-journal-title>
<issn pub-type="epub">2813-2440</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/frtra.2025.1595766</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Transplantation</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Males and females respond differently to treatment during isolated kidney perfusion: combined effects of glucocorticoid and estradiol</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Vidal-dos-Santos</surname><given-names>Marina</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2090535/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Armstrong-Jr</surname><given-names>Roberto</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2042995/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>de Assis Ramos</surname><given-names>Mayara Munhoz</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2077497/overview" /><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>da Anuncia&#x00E7;&#x00E3;o</surname><given-names>Lucas Ferreira</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Ricardo-da-Silva</surname><given-names>Fernanda Yamamoto</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Correia</surname><given-names>Cristiano de Jesus</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Ottens</surname><given-names>Petra J.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Luiz Felipe Pinho</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/786669/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Leuvenink</surname><given-names>Henri G. D.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/241076/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Breithaupt-Faloppa</surname><given-names>Ana Cristina</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1992709/overview" /><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Laboratorio de Cirurgia Cardiovascular e Fisiopatologia da Circula&#x00E7;&#x00E3;o (LIM-11), Instituto do Cora&#x00E7;&#x00E3;o (InCor), Faculdade de Medicina da Universidade de S&#x00E3;o Paulo</institution>, <addr-line>S&#x00E3;o Paulo</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Surgery, University Medical Centre Groningen, University of Groningen</institution>, <addr-line>Groningen</addr-line>, <country>Netherlands</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Sarah Tsou, Brigham and Women&#x0027;s Hospital and Harvard Medical School, United States</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Bulang He, Austin Hospital, Australia</p>
<p>Mukhammad Kayumov, Harvard Medical School, United States</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Ana Cristina Breithaupt-Faloppa <email>ana.breithaupt@hc.fm.usp.br</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>30</day><month>05</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>4</volume><elocation-id>1595766</elocation-id>
<history>
<date date-type="received"><day>18</day><month>03</month><year>2025</year></date>
<date date-type="accepted"><day>12</day><month>05</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Vidal-dos-Santos, Armstrong-Jr, de Assis Ramos, da Anuncia&#x00E7;&#x00E3;o, Ricardo-da-Silva, Correia, Ottens, Moreira, Leuvenink and Breithaupt-Faloppa.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Vidal-dos-Santos, Armstrong-Jr, de Assis Ramos, da Anuncia&#x00E7;&#x00E3;o, Ricardo-da-Silva, Correia, Ottens, Moreira, Leuvenink and Breithaupt-Faloppa</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>Kidney perfusion is a tool that allows organs to be assessed before transplantation. After brain death (BD), hormonal dysfunction can compromise graft quality. Hormonal treatment of donors has shown positive outcomes, and treatment during ex vivo perfusion may be advantageous. The combination of 17&#x03B2;-estradiol (E2) and methylprednisolone (MP) has been shown to modulate inflammation in donors. Therefore, this study aims to evaluate treatment with E2 and MP during isolated perfusion of kidneys in brain-dead male and female rats.</p>
</sec><sec><title>Methods</title>
<p>Female and male Wistar rats were submitted to BD and maintained for 4&#x2005;h. In the same animal, the right kidney [RK&#x2014;no isolated perfusion of kidney (IPK)] was removed and stored, while the left kidney (LK&#x2014;with IPK) had the ureter and the renal artery cannulated and flushed with 5&#x2005;ml of cold saline. The LK was then taken directly to the IPK system for 90&#x2005;min. Experimental groups were performed in both male and female: IPK (without treatment) and IPK&#x2009;&#x002B;&#x2009;Treat (MP and E2 added to the perfusate). Perfusion was performed with a constant pressure of 100&#x2005;mmHg, using William&#x0027;s Medium E supplemented with HEPES, creatinine, and albumin as perfusate. Perfusate and urine were collected, and flow measurements were recorded. After IPK, the LK was stored.</p>
</sec><sec><title>Results</title>
<p>IL-6 was reduced in all perfused groups, regardless of treatment. In female IPK&#x2009;&#x002B;&#x2009;Treat, there was a reduction in perfusion flow, followed by reduced creatinine clearance and Na<sup>&#x002B;</sup> excretion. No difference was observed in males in regards to treatment.</p>
</sec><sec><title>Conclusion</title>
<p>The combined treatment of E2 and MP during isolated kidney perfusion compromised kidney function in females. In males, no detrimental effects were observed. These results show a sex-dependent action of the proposed treatment.</p>
</sec>
</abstract>
<kwd-group>
<kwd>brain death</kwd>
<kwd>sex differences</kwd>
<kwd>machine perfusion</kwd>
<kwd>kidney</kwd>
<kwd>rat</kwd>
</kwd-group><contract-num rid="cn001">2020/11211-6, 2021/07455-0</contract-num><contract-num rid="cn002">2021/13020-6</contract-num><contract-sponsor id="cn001">Funda&#x00E7;&#x00E3;o de Amparo &#x00E0; Pesquisa do Estado de S&#x00E3;o Paulo-FAPESP</contract-sponsor><contract-sponsor id="cn002">FAPESP</contract-sponsor><contract-sponsor id="cn003">University of Groningen&#x2019;s Graduate School of Medical Sciences</contract-sponsor><counts>
<fig-count count="8"/>
<table-count count="3"/><equation-count count="2"/><ref-count count="32"/><page-count count="10"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Tissue Injury, Repair, Inflammation and Aging</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="background"><title>Background</title>
<p>In kidney transplantation, the majority of donations are derived from brain-dead patients (<xref ref-type="bibr" rid="B1">1</xref>). Brain death (BD) results from cranial trauma or hemorrhagic stroke that leads to an excessive increase in intracranial pressure, culminating in herniation of the brainstem and subsequent ischemia of the brain. This process triggers a hemodynamic imbalance via the release of catecholamines, resulting in systemic inflammation and hormonal dysfunction (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Our group has previously shown sex differences in an experimental model of BD, with females presenting a more exacerbated inflammatory response to BD induction (<xref ref-type="bibr" rid="B3">3</xref>). Additionally, a study by Armstrong-Jr et al. (<xref ref-type="bibr" rid="B4">4</xref>) has shown that sex differences persist during ex vivo perfusion of kidneys. The use of a perfusion system is a tool to assess and treat organs in a controlled and isolated environment before transplantation, and several therapeutic options have been explored to improve graft quality (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). Compared with methylprednisolone (MP) administration alone, the combination of 17&#x03B2;-estradiol (E2) and MP improved donor hemodynamics and modulated leukocyte infiltration into the lungs (<xref ref-type="bibr" rid="B8">8</xref>) and kidneys (unpublished data) in an experimental model of BD in females. These results point to a positive outcome of MP and E2 administration in the donor and in an isolated perfusion system in different organs. Therefore, we aimed to investigate how the association of MP and E2 could affect kidneys from male and female rats after a period of BD using a model of isolated perfusion of kidneys (IPK).</p>
</sec>
<sec id="s2" sec-type="methods"><title>Methods</title>
<sec id="s2a"><title>Animals</title>
<p>Female and male Wistar rats (8&#x2013;12 weeks old) from Envigo (the Netherlands) were maintained at 23&#x2009;&#x00B1;&#x2009;2&#x00B0;C, with a 12&#x2005;h light and dark cycle and food and water <italic>ad libitum</italic>. The animals were cared for in accordance with the Principles of Laboratory Animal Care (NIH Publication No. 86-23, revised 1985) and the Dutch Law on Experimental Animals Care. This study was approved by the Institutional Animal Care and Use Committee of the University of Groningen (IvD number: 171245-01-004).</p>
<p>The animals were allocated into groups: male and female naive, control animals that did not undergo any surgical procedure (<italic>n</italic>&#x2009;&#x003D;&#x2009;4); male and female BD, animals that underwent BD induction without IPK (<italic>n</italic>&#x2009;&#x003D;&#x2009;8); male and female IPK, animals that underwent BD, followed by IPK without treatment (<italic>n</italic>&#x2009;&#x003D;&#x2009;8); and male and female IPK&#x2009;&#x002B;&#x2009;Treat, animals that underwent BD, followed by IPK with the combined treatment of 17&#x03B2;-estradiol and methylprednisolone (<italic>n</italic>&#x2009;&#x003D;&#x2009;8).</p>
</sec>
<sec id="s2b"><title>Estrous cycle identification</title>
<p>The female animals were selected by estral cycle phase, identifying the higher estradiol period (estrous and proestrous). Vaginal lavage was performed with a Pasteur pipette filled with 10&#x2005;&#x03BC;l of saline solution (0.9&#x0025; NaCl). The cellular profile was identified by optical microscopy observation.</p>
</sec>
<sec id="s2c"><title>Brain death induction</title>
<p>All animals were placed in a closed chamber, anesthetized with 5&#x0025; isoflurane, and maintained with 2&#x0025; isoflurane during the surgical procedure. The temperature was maintained at 37&#x00B0;C via a heating mat. The jugular vein was cannulated for fluid administration and influx of vasoactive drugs for hemodynamic stabilization; the carotid artery was used for blood pressure measurements. The animals were connected to a small animal ventilator after tracheostomy (Harvard Apparatus, model 683, USA) and kept at a frequency of 70&#x2005;breaths/min and a tidal volume of 10&#x2005;ml/kg. For BD induction, a Fogarty 4F catheter was inserted into the intracranial space and slowly inflated for 30&#x2005;min. BD was confirmed by bilateral mydriasis and apnea. After BD confirmation, anesthesia was stopped, and fluid administration was initiated (2&#x2005;ml/h) until the end of the experiment. Blood samples were collected at the beginning and the end of the 4&#x2005;h period. After 4&#x2005;h, the animals were exsanguinated, and a whole-body flush (maximum pressure of 30&#x2005;mmHg) was performed with 40&#x2005;ml of cold saline. Blood, urine, and organs were collected. The left kidney (LK) was prepared for perfusion, while the right kidney was immediately snap-frozen. For the LK, a nephrectomy was performed. The ureter and the renal artery were cannulated, and the kidney was then flushed with 5&#x2005;ml of cold saline solution and directly transferred to the isolated kidney perfusion (IPK) system.</p>
</sec>
<sec id="s2d"><title>Normothermic isolated perfused kidney setup</title>
<p>For the IPK, pressure-controlled normothermic machine perfusion was performed via a roller pump (Ismatec ISM404, Switzerland). The pressure was constantly set at 100&#x2005;mmHg, and a pressure sensor (Edwards Lifesciences, USA) was placed close to the renal artery. For the perfusion solution, 100&#x2005;ml of William&#x0027;s medium E supplemented with 30&#x2005;mmol/L HEPES, 7&#x2005;mmol/L creatinine, and 50&#x2005;g/L albumin (Sigma-Aldrich, USA) was used. Carbogen (95&#x0025; O<sub>2</sub>, 5&#x0025; CO<sub>2</sub>) was used to oxygenate the perfusate at a flow rate of 0.5&#x2005;L/min. Perfusate gas analyses were performed at the initial and final points of IPK, and the values were maintained at approximately 525&#x2005;mmHg. A water bath and heat exchanger were used to heat the solution. In the first 30&#x2005;min of perfusion, temperature was slowly increased (1&#x00B0;C/2&#x2005;min) during the rewarming phase. After that, the temperature was kept at 37&#x00B0;C. Flow measurements were recorded during perfusion.</p>
<p>Perfusate and ultrafiltrate (urine) samples were collected at T15, T30, T60, and T90 (Tmin). After 90&#x2005;min, the LK was stored for further analysis.</p>
</sec>
<sec id="s2e"><title>Treatment</title>
<p>For treatment, 40&#x2009;mg of methylprednisolone and 5&#x2009;&#x03BC;g/ml of 17&#x03B2;-estradiol were added to the IPK perfusion solutions.</p>
</sec>
<sec id="s2f"><title>Biochemical analysis</title>
<p>lactate dehydrogenase (LDH) was measured in the IPK perfusate. Creatinine and Na<sup>&#x002B;</sup> levels were determined in the IPK perfusate and ultrafiltrate. Measurements were performed in accordance with the Clinical Laboratory, University Medical Center Groningen, following standard biochemical methods.</p>
</sec>
<sec id="s2g"><title>Creatinine clearance and Na excretion (FENa<sup>&#x002B;</sup>)</title>
<p>The creatinine and Na<sup>&#x002B;</sup> concentrations in the ultrafiltrate and perfusate obtained via biochemical analysis were used to estimate creatinine clearance and Na<sup>&#x002B;</sup> excretion via the following calculations:<disp-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="UDM1"><mml:mtable rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Creatinineclearance</mml:mi></mml:mrow><mml:mspace width=".1em"/><mml:mo>=</mml:mo><mml:mspace width=".1em"/><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">ultrafililtrate</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">creatinine</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">concentration</mml:mi><mml:mspace width=".1em"/></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi>&#x03BC;</mml:mi><mml:mi mathvariant="normal">mol</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mspace width=".1em"/><mml:mrow><mml:mspace width="0.25em"/><mml:mo>&#x00D7;</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width=".1em"/><mml:mrow><mml:mi mathvariant="normal">ultrafiltrate</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">production</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow><mml:mi mathvariant="normal">flow</mml:mi></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ml</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mrow><mml:mo>/</mml:mo><mml:mi mathvariant="normal">perfusion</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">solution</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">creatinine</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">concentration</mml:mi><mml:mspace width=".1em"/></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi>&#x03BC;</mml:mi><mml:mi mathvariant="normal">mol</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo>/</mml:mo><mml:mi mathvariant="normal">kidney</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">weight</mml:mi><mml:mspace width=".1em"/></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mi mathvariant="normal">g</mml:mi></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula><disp-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="UDM2"><mml:mtable columnalign="right left" rowspacing=".5em" columnspacing="thickmathspace" displaystyle="true"><mml:mtr><mml:mtd><mml:mrow><mml:mi mathvariant="normal">FEN</mml:mi></mml:mrow><mml:msup><mml:mi>a</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:mtext>&#x0025;</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mspace width=".1em"/><mml:mo>=</mml:mo></mml:mtd><mml:mtd><mml:mspace width=".1em"/><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">ultrafiltrate</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mspace width="0.25em"/><mml:mo>+</mml:mo><mml:mspace width=".1em"/></mml:mrow></mml:msup><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">mmol</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mspace width=".1em"/><mml:mrow><mml:mspace width="0.25em"/><mml:mo>&#x00D7;</mml:mo></mml:mrow><mml:mspace width=".1em"/><mml:mrow><mml:mi mathvariant="normal">creatinine</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">perfusate</mml:mi><mml:mspace width=".1em"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd /><mml:mtd><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">mmol</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mrow><mml:mo>/</mml:mo><mml:mi mathvariant="normal">perfusate</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mspace width="0.25em"/><mml:mo>+</mml:mo><mml:mspace width=".1em"/></mml:mrow></mml:msup><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">mmol</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mspace width=".1em"/><mml:mrow><mml:mspace width="0.25em"/><mml:mo>&#x00D7;</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd /><mml:mtd><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ultrafiltrate</mml:mi><mml:mspace width=".1em"/><mml:mi mathvariant="normal">creatinine</mml:mi><mml:mspace width=".1em"/></mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">mmol</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo><mml:mspace width=".1em"/><mml:mrow><mml:mspace width="0.25em"/><mml:mo>&#x00D7;</mml:mo></mml:mrow><mml:mspace width=".1em"/><mml:mn>100</mml:mn></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p>
</sec>
<sec id="s2h"><title>IL-6 quantification</title>
<p>IL-6 was measured in kidney homogenate and IPK perfusate. Quantifications were performed via Duo Set commercial ELISA kits (R&#x0026;D Systems, USA) in accordance with the manufacturer&#x0027;s specifications.</p>
</sec>
<sec id="s2i"><title>Gene expression</title>
<p>Total RNA was extracted from kidney tissue via TRIzol reagent (Invitrogen, USA). The yield of extracted RNA was analyzed with a NanoDrop 1000 spectrophotometer (NanoDrop Technologies, USA), and the quality was assessed via RNA electrophoresis. The extracted RNA was reverse transcribed with random primers at 37&#x00B0;C for 50&#x2005;min. Quantitative real-time polymerase chain reaction (qRT-PCR) was conducted with specific primers (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). SYBR Green (Applied Biosystems, the Netherlands) and a QuantStudio 7 Flex qPCR machine (Applied Biosystems, the Netherlands), which was configured with 1 cycle of 10&#x2005;min at 95&#x00B0;C and 40 consecutive cycles of 15 s at 95&#x00B0;C and 1&#x2005;min at 60&#x00B0;C. CT values were corrected for &#x03B2;-actin levels.</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>RT-PCR primers.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">Forward sequence</th>
<th valign="top" align="center">Reverse sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">&#x03B2;-Actin</td>
<td valign="top" align="left">GGAAATCGTGCGTGACATTAAA</td>
<td valign="top" align="left">GCGGCAGTGGCCATCTC</td>
</tr>
<tr>
<td valign="top" align="left">IL-6</td>
<td valign="top" align="left">CCAACTTCCAATGCTCTCCTAATG</td>
<td valign="top" align="left">TTCAAGTGCTTTCAAGAGTTGGAT</td>
</tr>
<tr>
<td valign="top" align="left">KIM-1</td>
<td valign="top" align="left">AGAGAGAGCAGGACACAGGCTTT</td>
<td valign="top" align="left">ACCCGTGGTAGTCCCAAACA</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>RT-PCR, real-time polymerase chain reaction; &#x03B2;-actin, beta-actin; IL-6, interleukin 6; KIM-1, kidney injury marker 1.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2j"><title>Immunohistochemistry</title>
<p>For the immunohistochemical analyses, the right and left kidneys were placed in formalin and subsequently paraffin-embedded. Slices (3&#x2005;mm) were prepared and placed on glass slides. Deparaffinization was performed via xylene and ethanol. Antigen retrieval was performed via the use of an ethylenediaminetetraacetic acid (EDTA) (pH 8) solution. The slides were incubated in this solution for 3&#x2005;h at 60&#x00B0;C. Later, endogenous peroxidase was blocked with H2O2 (2&#x0025;) for 15&#x2005;min. Non-specific blockage was performed with TBST-BSA (2&#x0025;) solution for 1&#x2005;h at 37&#x00B0;C. Antibodies against myeloperoxidase (MPO), inducible nitric oxide synthase (iNOS), kidney injury molecule-1 (KIM-1), endothelial nitric oxide synthase (eNOS), and endothelin-1 (ET-1) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>) were incubated with the samples overnight at 4&#x00B0;C. The sections were then incubated with secondary HRP-conjugated antibodies (1:200, BA1054; Boster Biological Technology, USA) for 2&#x2005;h at 37&#x00B0;C. A peroxidase substrate was subsequently used. Hematoxylin was used for counterstaining. For the slide analyses and image acquisition, NIS-Elements BD (Nikon, Japan) software was used.</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Primary antibodies.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Antibody</th>
<th valign="top" align="center">Dilution and code</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">MPO</td>
<td valign="top" align="center">1:50, PA1054; Boster Biological Technology, USA</td>
</tr>
<tr>
<td valign="top" align="left">iNOS</td>
<td valign="top" align="center">1:100, AB3523; Abcam, UK</td>
</tr>
<tr>
<td valign="top" align="left">KIM-1</td>
<td valign="top" align="center">1:100, LS-C312791; LSBio, USA</td>
</tr>
<tr>
<td valign="top" align="left">eNOS</td>
<td valign="top" align="center">1:100, AO1604-2; Boster Biological Technology, USA</td>
</tr>
<tr>
<td valign="top" align="left">Endothelin-1</td>
<td valign="top" align="center">1:200, LS-B13907; LSBio, USA</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2"><p>MPO, myeloperoxidase; iNOS, inducible nitric oxide synthase; KIM-1, kidney injury marker 1; eNOS, endothelial nitric oxide synthase.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2k"><title>Morphological analysis</title>
<p>Kidney morphology was analyzed via periodic acid&#x2013;Schiff (PAS) staining of paraffin-embedded kidney sections (5&#x2005;&#x03BC;m). The scoring system used is presented in <xref ref-type="table" rid="T3">Table&#x00A0;3</xref>.</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Morphological analysis scoring system.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Analyses</th>
<th valign="top" align="center" colspan="4">Scoring system</th>
</tr>
<tr>
<th valign="top" align="center">0</th>
<th valign="top" align="center">1</th>
<th valign="top" align="center">2</th>
<th valign="top" align="center">3</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Dilated glomerulus</td>
<td valign="top" align="left">Normal glomerular space</td>
<td valign="top" align="left">Moderately enlarged glomerular space</td>
<td valign="top" align="left">Enlarged glomerular space</td>
<td valign="top" align="left">Greatly enlarged glomerular space</td>
</tr>
<tr>
<td valign="top" align="left">Necrosis of the proximal tubule</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">Partly broken brush border, shedding and blebbing, and normal nucleus</td>
<td valign="top" align="left">&#x003E;50&#x0025; broken brush border, loose cell nuclei, and pyknotic nuclei</td>
<td valign="top" align="left">More than half of the tubules are necrotic</td>
</tr>
<tr>
<td valign="top" align="left">Necrosis of the distal tubule</td>
<td valign="top" align="left">&#x2013;</td>
<td valign="top" align="left">Partly loose cells</td>
<td valign="top" align="left">&#x003E;50&#x0025; loose cells and pyknotic nuclei</td>
<td valign="top" align="left">&#x2013;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2l"><title>Statistical analysis</title>
<p>The data are expressed as the means&#x2009;&#x00B1;&#x2009;standard errors of the means (SEMs). The data were analyzed with GraphPad Prism Version 10, and the groups were compared via two-way analysis followed by the <italic>post hoc</italic> test of the two-stage linear step-up procedure of Benjamin, Krieger, and Yekutieli or three-way ANOVA.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><title>Results</title>
<sec id="s3a"><title>Expression and release of IL-6</title>
<p>IL-6 (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>) was quantified in kidney homogenates (A) and IPK perfusates (B). Gene expression in renal tissue was also evaluated (C). Compared with non-perfused kidneys, all groups presented reduced expression of IL-6 in kidney homogenates after perfusion. For males, the treated group presented even lower concentrations than those in the non-treated group. In females, no difference was observed between the IPK and IPK&#x2009;&#x002B;&#x2009;Treat groups (A). According to the results of the perfusate analyses, female IPK&#x2009;&#x002B;&#x2009;Treat mice presented lower release of IL-6 than IPK-treated mice did. No difference was observed in males (B). Finally, gene expression was increased in all groups after IPK, regardless of sex and treatment (C).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Quantification of IL-6 in kidney homogenate <bold>(A)</bold>, IPK perfusate <bold>(B)</bold>, and gene expression in kidney tissue <bold>(C)</bold>. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results from graphs A and C were analyzed using three-way ANOVA. Results from graph B were analyzed using two-way ANOVA. IL-6, interleukin 6.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g001.tif"/>
</fig>
</sec>
<sec id="s3b"><title>Leukocyte infiltrate</title>
<p>The number of infiltrating neutrophils and macrophages was analyzed via quantification of MPO-marked cells and iNOS protein expression (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>). The pre-IPK kidneys of males presented higher MPO levels than did those of females. After IPK, all groups presented similar numbers of infiltrated cells (A). Similarly, in the iNOS analyses, protein expression was increased in males and was reduced after perfusion in all the groups.</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Protein expression of MPO and iNOS in kidney tissue. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results analyzed using three-way ANOVA. MPO, myeloperoxidase. iNOS, inducible nitric oxide synthase.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g002.tif"/>
</fig>
</sec>
<sec id="s3c"><title>Kidney injury marker 1 (KIM-1) expression</title>
<p>There was a reduction in the protein expression of KIM-1 with perfusion. With respect to gene expression, no difference was observed among the groups (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>).</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Protein and gene expression of KIM-1 in kidney tissue. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results analyzed using three-way ANOVA. KIM-1, kidney injury marker 1.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g003.tif"/>
</fig>
</sec>
<sec id="s3d"><title>Flow measurement</title>
<p>Perfusion flow was constantly measured during IPK. Females presented with slightly increased flow at the beginning of perfusion. Compared with the control group, the IPK&#x2009;&#x002B;&#x2009;Treat group presented significantly reduced flow. The male groups presented similar values throughout perfusion (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>).</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Flow measurement during perfusion. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results analyzed using three-way ANOVA.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g004.tif"/>
</fig>
</sec>
<sec id="s3e"><title>Modulation of vascular tone</title>
<p>The protein expression of eNOS and endothelin-1 (ET-1) was analyzed in kidney tissue (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>). In females, eNOS expression was reduced in pre-IPK kidneys, and eNOS expression was increased in the IPK&#x2009;&#x002B;&#x2009;Treat group (A). No difference was observed in the male groups. With respect to ET-1 (B), females also presented reduced expression in pre-IPK kidneys compared with males, and no difference was observed with perfusion or treatment.</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Protein expression of eNOS and endothelin-1 in kidney tissue. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results analyzed using three-way ANOVA. eNOS, endothelial nitric oxide synthase.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g005.tif"/>
</fig>
</sec>
<sec id="s3f"><title>Kidney function</title>
<p>Creatinine clearance was lower in males than in females, and female IPK&#x2009;&#x002B;&#x2009;Treat presents lower values than female IPK does. No difference was observed over time (A). Fractional excretion of sodium (FENa) in the perfusate revealed greater reabsorption of Na<sup>&#x002B;</sup> in the female IPK&#x2009;&#x002B;&#x2009;Treat group than in the female IPK group. Both male groups presented similar values at all 90&#x2005;min (B). Over time, all groups presented a reduction in FENa<sup>&#x002B;</sup> (<xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>).</p>
<fig id="F6" position="float"><label>Figure 6</label>
<caption><p>Creatinine clearance and fractional excretion of sodium. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results analyzed using three-way ANOVA. FENa, fractional excretion of sodium.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g006.tif"/>
</fig>
</sec>
<sec id="s3g"><title>Lactate dehydrogenase (LDH) and lactate</title>
<p>LDH was measured in the perfusate at several time points (A). Lactate was quantified at the beginning and end of the perfusion (B). There is an increase in LDH in both male and female IPK&#x2009;&#x002B;&#x2009;Treat groups compared with IPK. All groups presented an increase in LDH throughout perfusion. Lastly, all groups presented increased lactate from T15 to T90 (<xref ref-type="fig" rid="F7">Figure&#x00A0;7</xref>).</p>
<fig id="F7" position="float"><label>Figure 7</label>
<caption><p>Lactate dehydrogenase and lactate quantification. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results analyzed using three-way ANOVA. LDH, lactate dehydrogenase.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g007.tif"/>
</fig>
</sec>
<sec id="s3h"><title>Morphological analysis of renal tissue</title>
<p>Necrosis of the proximal and distal tubules and glomerular space was quantified via a scoring system (<xref ref-type="fig" rid="F8">Figure&#x00A0;8</xref>). Both proximal and distal necrosis were reduced after perfusion in all groups (A and B). Compared with non-perfused kidneys, all perfused kidneys presented increased glomerular space (C).</p>
<fig id="F8" position="float"><label>Figure 8</label>
<caption><p>Morphological analysis of kidney tissue. Necrosis of the proximal tubule <bold>(A)</bold>, necrosis of the distal tubule <bold>(B)</bold>, and glomerular space <bold>(C)</bold>. IPK, kidneys that underwent isolated perfusion without treatment; IPK&#x2009;&#x002B;&#x2009;Treat, kidneys that underwent isolated perfusion with treatment of 17&#x03B2;-estradiol and methylprednisolone. Results are presented as mean and standard error of the mean. Results were analyzed using three-way ANOVA. Representative images are presented (20&#x00D7;).</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="frtra-04-1595766-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><title>Discussion</title>
<p>We investigated the effects of E2 and MP on kidney injury during normothermic isolated perfusion to improve graft quality. Previously, Armstrong-Jr et al. (<xref ref-type="bibr" rid="B4">4</xref>) highlighted sex differences during perfusion using the same experimental BD model. Their study revealed increased cellular infiltration in males, especially of macrophages, and reduced creatinine clearance compared with females. In our work, we observed a reduction in inflammation in all perfused groups, regardless of treatment and sex, with decreased protein expression of IL-6 in kidney tissues and a reduced presence of leukocytes in the parenchyma. In terms of treatment, female IPK&#x2009;&#x002B;&#x2009;Treat presented reduced flow compared with female IPK, accompanied by decreased creatinine clearance and increased fractional excretion of sodium, whereas males presented similar renal function results in the treated and non-treated groups.</p>
<p>The first clinical ex vivo kidney perfusion was performed in 2011 to serve as a platform to preserve, assess, and repair kidneys before transplantation (<xref ref-type="bibr" rid="B9">9</xref>). Several protocols have been tested to provide a near-physiological environment (<xref ref-type="bibr" rid="B10">10</xref>), and studies have linked normothermic kidney perfusion (NKP) to inflammation (<xref ref-type="bibr" rid="B11">11</xref>). To date, there is no consensus on the appropriate perfusion conditions and ideal biomarkers for evaluating graft quality. Perfusion solutions usually include red blood cells (RBCs) or even whole blood as oxygen carriers (<xref ref-type="bibr" rid="B12">12</xref>), and such compositions can lead to complement activation, even with the use of leukocyte filters or plasma-free perfusate (<xref ref-type="bibr" rid="B13">13</xref>). De Beule et al. (<xref ref-type="bibr" rid="B14">14</xref>) compared RBCs and whole blood-based solutions during the NKP of ischemic and nonischemic kidneys. Their results point to increased renal damage, with reduced oxygen consumption and increased levels of injury markers in kidneys that underwent warm and cold ischemia periods, with no differences related to perfusate type. These results suggest that increased inflammation during NKP may also be related to reperfusion injury triggered by blood-derived products. In our study, we observed a reduced IL-6 concentration in kidney tissue after perfusion and a reduced presence of infiltrating neutrophils. These findings could be related to the use of RBC-free perfusate, which mitigates the inflammatory response triggered by blood components. No evidence is available on ideal oxygenation during NKP, but most experimental protocols use supraphysiological concentrations, and even though no oxygen carrier was used, our perfusion solution was able to provide pO<sub>2</sub> values above 500&#x2005;mmHg.</p>
<p>Additionally, perfusion flow was evaluated throughout the 90&#x2005;min of perfusion. In treated females, reduced flow was reflected in lower creatinine clearance rates and increased FENa<sup>&#x002B;</sup>. FENa<sup>&#x002B;</sup> is calculated to assess sodium handling by the kidney and is used to evaluate acute kidney injury. Usually, values &#x003C;1&#x0025; may suggest prerenal diseases; however, greater reabsorption of Na<sup>&#x002B;</sup> represents an appropriate response to reduced kidney perfusion (<xref ref-type="bibr" rid="B15">15</xref>). In a canine model, Dvorak et al. (<xref ref-type="bibr" rid="B16">16</xref>) evaluated the administration of several doses of MP during isolated perfusion of kidneys from female dogs and reported that high-dose MP (0.32&#x2005;mg/ml) led to increased perfusion pressure and reduced perfusion flow. In our study, a similar dose was used (0.40&#x2005;mg/ml), which could explain the reduction in flow observed in the female IPK&#x2009;&#x002B;&#x2009;Treat group. In women, pharmacokinetic studies focused on premenopausal kidney transplant recipients have shown that the MP clearance rate is lower in women than in men (<xref ref-type="bibr" rid="B17">17</xref>). The same phenomenon is observed in the physiological clearance of MPs (<xref ref-type="bibr" rid="B18">18</xref>). However, in the clinic, a standardized dose protocol is used, with no consideration of the age or sex of the patient (<xref ref-type="bibr" rid="B19">19</xref>), highlighting the importance of studies focusing on sex differences.</p>
<p>Additionally, activation of the mineralocorticoid receptor (MR) in the kidney by the hormone aldosterone promotes Na<sup>&#x002B;</sup> retention and hypertension. Although MRs present high affinity for aldosterone, other glucocorticoids, such as cortisol, can interact with and activate such receptors (<xref ref-type="bibr" rid="B20">20</xref>). Exogenous glucocorticoids were initially considered free of cross-activation of MR; however, Rebuffat et al. (<xref ref-type="bibr" rid="B21">21</xref>) reported that dexamethasone was able to occupy MR and promote its translocation to the nucleus. Several studies have shown that female mice and humans present increased expression of endothelial MRs and are at increased risk of vascular damage mediated by MR activation (<xref ref-type="bibr" rid="B22">22</xref>&#x2013;<xref ref-type="bibr" rid="B24">24</xref>). In our model, MP administration in females may have activated MR in the renal endothelium, leading to vascular damage. Therefore, we also investigated the modulation of vascular tone by quantifying the protein expression of ET-1 and eNOS in kidney tissue and observed reduced expression of ET-1 in females compared with males. In the literature, studies have shown sex differences in ET-1 expression, with lower levels in females, under both physiological and pathological conditions, and such findings have been associated with higher E2 concentrations (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>). E2 is also known to stimulate eNOS activation/expression (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>), and our group has previously shown that treatment of donors with E2 after BD can increase eNOS (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Although eNOS is constitutively expressed, several chemical and physical stimuli affect eNOS expression/activity. For example, fluid shear stress generated in vessels during perfusion can activate eNOS mRNA and protein expression (<xref ref-type="bibr" rid="B32">32</xref>). Indeed, our results revealed that females presented increased protein expression of eNOS in both perfused groups, especially in the IPK&#x2009;&#x002B;&#x2009;Treat group.</p>
<p>This study has some limitations. Our protocol uses a small animal model, and correlation to the clinic is limited. Further studies should be conducted in larger animals or discarded human kidneys for a more translational application. Moreover, a transplantation model would also be of interest, aiming to evaluate the effect of the proposed treatment on the recipient.</p>
<p>In conclusion, the data presented in this study show that perfusion alone was able to ameliorate inflammation by reducing the number of infiltrated leukocytes and the expression of IL-6, as well as ameliorating kidney injury by reducing the protein expression of KIM-1 and necrosis of the distal and proximal tubules. Specifically, in males, the use of the proposed treatment had no detrimental effects during perfusion, with the analyzed parameters remaining similar. In females, treatment with E2 and MP had deleterious effects on isolated kidneys, especially by reducing perfusion flow and consequently compromising kidney function. In a parallel study (data not published) using an ex vivo lung perfusion model, the combination of E2 and MP improved lung function in males and modulated inflammation in females, indicating that treatment effectiveness might be organ- and sex-dependent. Subsequent studies should aim to evaluate both male and female subjects, as sex differences may modulate preservation techniques and treatments in positive or negative ways. Thus, personalized protocols could represent the future of graft management.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability"><title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The animal study was approved by the Institutional Animal Care and Use Committee of the University of Groningen (IACUC-RUG). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions"><title>Author contributions</title>
<p>MV-d-S: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. RA-J: Data curation, Formal analysis, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. MA: Data curation, Formal analysis, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. LA: Data curation, Formal analysis, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. FR-d-S: Data curation, Formal analysis, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. CC: Data curation, Formal analysis, Funding acquisition, Visualization, Writing &#x2013; review &#x0026; editing. PO: Data curation, Formal analysis, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. LM: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. HL: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. AB-F: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information"><title>Funding</title>
<p>The authors declare that financial support was received for the research and/or publication of this article. LFPM is a fellow researcher of the CNPq. The author MV-d-S is a scholarship holder by Funda&#x00E7;&#x00E3;o de Amparo &#x00E0; Pesquisa do Estado de S&#x00E3;o Paulo-FAPESP&#x2014;2020/11211-6 and later 2021/07455-0. The author FR-d-S is a scholarship holder by FAPESP&#x2014;2021/13020-6. The University of Groningen&#x2019;s Graduate School of Medical Sciences also provided funding for this project.</p>
</sec>
<sec id="s9" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s11" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="other"><article-title>Eurotransplant Annual Report</article-title>. (<year>2023</year>). <comment>Available at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.eurotransplant.org/statistics/annual-report/">https://www.eurotransplant.org/statistics/annual-report/</ext-link> (<comment>Accessed February 5, 2025</comment>).</citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westendorp</surname><given-names>WH</given-names></name><name><surname>Leuvenink</surname><given-names>HG</given-names></name><name><surname>Ploeg</surname><given-names>RJ</given-names></name></person-group>. <article-title>Brain death induced renal injury</article-title>. <source>Curr Opin Organ Transpl</source>. (<year>2011</year>) <volume>16</volume>:<fpage>151</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/MOT.0b013e328344a5dc</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breithaupt-Faloppa</surname><given-names>AC</given-names></name><name><surname>Ferreira</surname><given-names>SG</given-names></name><name><surname>Kudo</surname><given-names>GK</given-names></name><name><surname>Armstrong-Jr</surname><given-names>R</given-names></name><name><surname>Tavares-de-Lima</surname><given-names>W</given-names></name><name><surname>da Silva</surname><given-names>LF</given-names></name><etal/></person-group> <article-title>Sex-related differences in lung inflammation after brain death</article-title>. <source>J Surg Res</source>. (<year>2016</year>) <volume>200</volume>(<issue>2</issue>):<fpage>714</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2015.09.018</pub-id><pub-id pub-id-type="pmid">26547667</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstrong-Jr</surname><given-names>R</given-names></name><name><surname>Ricardo-da-Silva</surname><given-names>FY</given-names></name><name><surname>Vidal-Dos-Santos</surname><given-names>M</given-names></name><name><surname>da Anuncia&#x00E7;&#x00E3;o</surname><given-names>LF</given-names></name><name><surname>Ottens</surname><given-names>PJ</given-names></name><name><surname>Correia</surname><given-names>CJ</given-names></name><etal/></person-group> <article-title>Comparison of acute kidney injury following brain death between male and female rats</article-title>. <source>Clinics (Sao Paulo)</source>. (<year>2023</year>) <volume>78</volume>:<fpage>100222</fpage>. <pub-id pub-id-type="doi">10.1016/j.clinsp.2023.100222</pub-id><pub-id pub-id-type="pmid">37257364</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maassen</surname><given-names>H</given-names></name><name><surname>Venema</surname><given-names>LH</given-names></name><name><surname>Weiss</surname><given-names>MG</given-names></name><name><surname>Huijink</surname><given-names>TM</given-names></name><name><surname>Hofker</surname><given-names>HS</given-names></name><name><surname>Keller</surname><given-names>AK</given-names></name><etal/></person-group> <article-title>H2S-enriched flush out does not increase donor organ quality in a porcine kidney perfusion model</article-title>. <source>Antioxidants (Basel)</source>. (<year>2023</year>) <volume>12</volume>(<issue>3</issue>):<fpage>749</fpage>. <pub-id pub-id-type="doi">10.3390/antiox12030749</pub-id><pub-id pub-id-type="pmid">36978997</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogurlu</surname><given-names>B</given-names></name><name><surname>Pamplona</surname><given-names>CC</given-names></name><name><surname>Van Tricht</surname><given-names>IM</given-names></name><name><surname>Hamelink</surname><given-names>TL</given-names></name><name><surname>Lantinga</surname><given-names>VA</given-names></name><name><surname>Leuvenink</surname><given-names>HGD</given-names></name><etal/></person-group> <article-title>Prolonged controlled oxygenated rewarming improves immediate tubular function and energetic recovery of porcine kidneys during normothermic machine perfusion</article-title>. <source>Transplantation</source>. (<year>2023</year>) <volume>107</volume>(<issue>3</issue>):<fpage>639</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000004427</pub-id><pub-id pub-id-type="pmid">36525548</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lohmann</surname><given-names>S</given-names></name><name><surname>Eijken</surname><given-names>M</given-names></name><name><surname>M&#x00F8;ldrup</surname><given-names>U</given-names></name><name><surname>M&#x00F8;ller</surname><given-names>BK</given-names></name><name><surname>Hunter</surname><given-names>J</given-names></name><name><surname>Moers</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Ex vivo administration of mesenchymal stromal cells in kidney grafts against ischemia-reperfusion injury-effective delivery without kidney function improvement posttransplant</article-title>. <source>Transplantation</source>. (<year>2021</year>) <volume>105</volume>(<issue>3</issue>):<fpage>517</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000003429</pub-id><pub-id pub-id-type="pmid">32956281</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vidal-Dos-Santos</surname><given-names>M</given-names></name><name><surname>Anuncia&#x00E7;&#x00E3;o</surname><given-names>LF</given-names></name><name><surname>Armstrong-Jr</surname><given-names>R</given-names></name><name><surname>Ricardo-da-Silva</surname><given-names>FY</given-names></name><name><surname>Ramos</surname><given-names>IYT</given-names></name><name><surname>Correia</surname><given-names>CJ</given-names></name><etal/></person-group> <article-title>17<italic>&#x03B2;</italic>-estradiol and methylprednisolone association as a therapeutic option to modulate lung inflammation in brain-dead female rats</article-title>. <source>Front Immunol</source>. (<year>2024</year>) <volume>15</volume>:<fpage>1375943</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2024.1375943</pub-id><pub-id pub-id-type="pmid">38765005</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hosgood</surname><given-names>S</given-names></name><name><surname>Nicholson</surname><given-names>M</given-names></name></person-group>. <article-title>First in man renal transplantation after ex-vivo normothermic perfusion</article-title>. <source>Transplantation</source>. (<year>2011</year>) <volume>92</volume>:<fpage>735</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0b013e31822d4e04</pub-id><pub-id pub-id-type="pmid">21841540</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>TR</given-names></name><name><surname>Nicholson</surname><given-names>ML</given-names></name><name><surname>Hosgood</surname><given-names>SA</given-names></name></person-group>. <article-title>Normothermic kidney perfusion: an overview of protocols and strategies</article-title>. <source>Am J Transplant</source>. (<year>2021</year>) <volume>21</volume>(<issue>4</issue>):<fpage>1382</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.16307</pub-id><pub-id pub-id-type="pmid">32897651</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mellati</surname><given-names>A</given-names></name><name><surname>Lo Faro</surname><given-names>L</given-names></name><name><surname>Dumbill</surname><given-names>R</given-names></name><name><surname>Meertens</surname><given-names>P</given-names></name><name><surname>Rozenberg</surname><given-names>K</given-names></name><name><surname>Shaheed</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Kidney normothermic machine perfusion can be used as a preservation technique and a model of reperfusion to deliver novel therapies and assess inflammation and immune activation</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>850271</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.850271</pub-id><pub-id pub-id-type="pmid">35720316</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamelink</surname><given-names>TL</given-names></name><name><surname>Ogurlu</surname><given-names>B</given-names></name><name><surname>De Beule</surname><given-names>J</given-names></name><name><surname>Lantinga</surname><given-names>VA</given-names></name><name><surname>Pool</surname><given-names>MBF</given-names></name><name><surname>Venema</surname><given-names>LH</given-names></name><etal/></person-group> <article-title>Renal normothermic machine perfusion: the road toward clinical implementation of a promising pretransplant organ assessment tool</article-title>. <source>Transplantation</source>. (<year>2022</year>) <volume>106</volume>(<issue>2</issue>):<fpage>268</fpage>&#x2013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000003817</pub-id><pub-id pub-id-type="pmid">33979315</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname><given-names>E</given-names></name><name><surname>Sokolova</surname><given-names>M</given-names></name><name><surname>Jager</surname><given-names>NM</given-names></name><name><surname>Schjalm</surname><given-names>C</given-names></name><name><surname>Weiss</surname><given-names>MG</given-names></name><name><surname>Liav&#x00E5;g</surname><given-names>OM</given-names></name><etal/></person-group> <article-title>Normothermic machine perfusion reconstitutes porcine kidney tissue metabolism but induces an inflammatory response, which is reduced by complement C5 inhibition</article-title>. <source>Transpl Int</source>. (<year>2024</year>) <volume>37</volume>:<fpage>13348</fpage>. <pub-id pub-id-type="doi">10.3389/ti.2024.13348</pub-id><pub-id pub-id-type="pmid">39606689</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Beule</surname><given-names>J</given-names></name><name><surname>Keppens</surname><given-names>D</given-names></name><name><surname>Korf</surname><given-names>H</given-names></name><name><surname>Jochmans</surname><given-names>I</given-names></name></person-group>. <article-title>Differential cytokine levels during normothermic kidney perfusion with whole blood- or red blood cell-based perfusates&#x2014;results of a scoping review and experimental study</article-title>. <source>J Clin Med</source>. (<year>2022</year>) <volume>11</volume>:<fpage>6618</fpage>. <pub-id pub-id-type="doi">10.3390/jcm11226618</pub-id><pub-id pub-id-type="pmid">36431095</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Okusa</surname><given-names>MD</given-names></name><name><surname>Chopra</surname><given-names>TA</given-names></name></person-group>. <article-title>Fractional excretion of sodium, urea, and other molecules in acute kidney injury</article-title>. <publisher-loc>United States</publisher-loc>: <publisher-name>Wolters Kluwer</publisher-name> (<year>2025</year>). <comment>Available at:</comment> <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/fractional-excretion-of-sodium-urea-and-other-molecules-in-acute-kidney-injury#">https://www.uptodate.com/contents/fractional-excretion-of-sodium-urea-and-other-molecules-in-acute-kidney-injury&#x0023;</ext-link> (<comment>Accessed February 3, 2025</comment>).</citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dvorak</surname><given-names>K</given-names></name><name><surname>Braun</surname><given-names>W</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Stowe</surname><given-names>N</given-names></name><name><surname>Banowsky</surname><given-names>L</given-names></name></person-group>. <article-title>Effect of high doses of methylprednisolone on the isolated, perfused canine kidney</article-title>. <source>Transplantation</source>. (<year>1976</year>) <volume>21</volume>:<fpage>149</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1097/00007890-197602000-00010</pub-id><pub-id pub-id-type="pmid">1251463</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tornatore</surname><given-names>K</given-names></name><name><surname>Gilliland-Johnson</surname><given-names>K</given-names></name><name><surname>Farooqui</surname><given-names>M</given-names></name><name><surname>Reed</surname><given-names>K</given-names></name><name><surname>Venuto</surname><given-names>R</given-names></name></person-group>. <article-title>Pharmacokinetics and pharmacodynamic response of methylprednisolone in premenopausal renal transplant recipients</article-title>. <source>J Clin Pharmacol</source>. (<year>2004</year>) <volume>44</volume>:<fpage>1003</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1177/0091270004268130</pub-id><pub-id pub-id-type="pmid">15317828</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayyar</surname><given-names>V</given-names></name><name><surname>DuBois</surname><given-names>D</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Almon</surname><given-names>R</given-names></name><name><surname>Jusko</surname><given-names>W</given-names></name></person-group>. <article-title>Modeling corticosteroid pharmacokinetics and pharmacodynamics, part II: sex differences in methylprednisolone pharmacokinetics and corticosterone suppression</article-title>. <source>J Pharmacol Exp Ther</source>. (<year>2019</year>) <volume>370</volume>:<fpage>327</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.119.257527</pub-id><pub-id pub-id-type="pmid">31197019</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tornatore</surname><given-names>KM</given-names></name><name><surname>Biocevich</surname><given-names>DM</given-names></name><name><surname>Reed</surname><given-names>K</given-names></name><name><surname>Tousley</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>JP</given-names></name><name><surname>Venuto</surname><given-names>RC</given-names></name></person-group>. <article-title>Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients</article-title>. <source>Transplantation</source>. (<year>1995</year>) <volume>59</volume>(<issue>5</issue>):<fpage>729</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1097/00007890-199503150-00016</pub-id><pub-id pub-id-type="pmid">7886801</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>FJ</given-names></name><name><surname>Odermatt</surname><given-names>A</given-names></name><name><surname>Frey</surname><given-names>BM</given-names></name></person-group>. <article-title>Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension</article-title>. <source>Curr Opin Nephrol Hypertens</source>. (<year>2004</year>) <volume>13</volume>(<issue>4</issue>):<fpage>451</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/01.mnh.0000133976.32559.b0</pub-id><pub-id pub-id-type="pmid">15199296</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rebuffat</surname><given-names>AG</given-names></name><name><surname>Tam</surname><given-names>S</given-names></name><name><surname>Nawrocki</surname><given-names>AR</given-names></name><name><surname>Baker</surname><given-names>ME</given-names></name><name><surname>Frey</surname><given-names>BM</given-names></name><name><surname>Frey</surname><given-names>FJ</given-names></name><etal/></person-group> <article-title>The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2004</year>) <volume>214</volume>(<issue>1-2</issue>):<fpage>27</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2003.11.027</pub-id><pub-id pub-id-type="pmid">15062542</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>JL</given-names></name><name><surname>Belin de Chantem&#x00E8;le</surname><given-names>EJ</given-names></name></person-group>. <article-title>Mineralocorticoid receptor and endothelial dysfunction in hypertension</article-title>. <source>Curr Hypertens Rep</source>. (<year>2019</year>) <volume>21</volume>(<issue>10</issue>):<fpage>78</fpage>. <pub-id pub-id-type="doi">10.1007/s11906-019-0981-4</pub-id><pub-id pub-id-type="pmid">31485760</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>JL</given-names></name><name><surname>Kennard</surname><given-names>S</given-names></name><name><surname>Huby</surname><given-names>AC</given-names></name><name><surname>Antonova</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Jaffe</surname><given-names>IZ</given-names></name><etal/></person-group> <article-title>Progesterone predisposes females to obesity-associated leptin-mediated endothelial dysfunction via upregulating endothelial MR (mineralocorticoid receptor) expression</article-title>. <source>Hypertension</source>. (<year>2019</year>) <volume>74</volume>(<issue>3</issue>):<fpage>678</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.12802</pub-id><pub-id pub-id-type="pmid">31327274</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>JL</given-names></name><name><surname>Harwood</surname><given-names>D</given-names></name><name><surname>Kennard</surname><given-names>S</given-names></name><name><surname>Antonova</surname><given-names>G</given-names></name><name><surname>Clere</surname><given-names>N</given-names></name><name><surname>Belin de Chantem&#x00E8;le</surname><given-names>EJ</given-names></name></person-group>. <article-title>Dietary sodium restriction sex-specifically impairs endothelial function via mineralocorticoid receptor-dependent reduction in NO bioavailability in balb/C mice</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. (<year>2020</year>) <volume>320</volume>(<issue>1</issue>):<fpage>H211</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00413.2020</pub-id><pub-id pub-id-type="pmid">33095056</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyauchi</surname><given-names>T</given-names></name><name><surname>Yanagisawa</surname><given-names>M</given-names></name><name><surname>Iida</surname><given-names>K</given-names></name><name><surname>Ajisaka</surname><given-names>R</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Fujino</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects</article-title>. <source>Am Heart J.</source> (<year>1992</year>) <volume>123</volume>(<issue>4 Pt 1</issue>):<fpage>1092</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/0002-8703(92)90734-d</pub-id><pub-id pub-id-type="pmid">1549986</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polderman</surname><given-names>KH</given-names></name><name><surname>Stehouwer</surname><given-names>CD</given-names></name><name><surname>van Kamp</surname><given-names>GJ</given-names></name><name><surname>Dekker</surname><given-names>GA</given-names></name><name><surname>Verheugt</surname><given-names>FW</given-names></name><name><surname>Gooren</surname><given-names>LJ</given-names></name></person-group>. <article-title>Influence of sex hormones on plasma endothelin levels</article-title>. <source>Ann Intern Med.</source> (<year>1993</year>) <volume>118</volume>(<issue>6</issue>):<fpage>429</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-118-6-199303150-00006</pub-id><pub-id pub-id-type="pmid">8439117</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polderman</surname><given-names>KH</given-names></name><name><surname>Stehouwer</surname><given-names>CD</given-names></name><name><surname>van Kamp</surname><given-names>GJ</given-names></name><name><surname>Schalkwijk</surname><given-names>CG</given-names></name><name><surname>Gooren</surname><given-names>LJ</given-names></name></person-group>. <article-title>Modulation of plasma endothelin levels by the menstrual cycle</article-title>. <source>Metabolism</source>. (<year>2000</year>) <volume>49</volume>(<issue>5</issue>):<fpage>648</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/s0026-0495(00)80042-6</pub-id><pub-id pub-id-type="pmid">10831177</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goetz</surname><given-names>R</given-names></name><name><surname>Thatte</surname><given-names>H</given-names></name><name><surname>Prabhakar</surname><given-names>P</given-names></name><name><surname>Cho</surname><given-names>M</given-names></name><name><surname>Michel</surname><given-names>T</given-names></name><name><surname>Golan</surname><given-names>D</given-names></name></person-group>. <article-title>Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>1999</year>) <volume>96</volume>(<issue>6</issue>):<fpage>2788</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1073/PNAS.96.6.2788</pub-id><pub-id pub-id-type="pmid">10077589</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Musicki</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Strong</surname><given-names>T</given-names></name><name><surname>Lagoda</surname><given-names>G</given-names></name><name><surname>Bivalacqua</surname><given-names>T</given-names></name><name><surname>Burnett</surname><given-names>A</given-names></name></person-group>. <article-title>Post-translational regulation of endothelial nitric oxide synthase (eNOS) by estrogens in the rat vagina</article-title>. <source>J Sex Med</source>. (<year>2010</year>) <volume>7</volume>(<issue>5</issue>):<fpage>1768</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2010.01750.x</pub-id><pub-id pub-id-type="pmid">20233295</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstrong-Jr</surname><given-names>R</given-names></name><name><surname>Ricardo-da-Silva</surname><given-names>FY</given-names></name><name><surname>Correia</surname><given-names>CJ</given-names></name><name><surname>Vidal-Dos-Santos</surname><given-names>M</given-names></name><name><surname>da Anuncia&#x00E7;&#x00E3;o</surname><given-names>LF</given-names></name><name><surname>Coutinho E Silva</surname><given-names>RS</given-names></name><etal/></person-group> <article-title>Treatment with 17<italic>&#x03B2;</italic>-estradiol protects donor heart against brain death effects in female rat</article-title>. <source>Transpl Int</source>. (<year>2020</year>) <volume>33</volume>(<issue>10</issue>):<fpage>1312</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/tri.13687</pub-id><pub-id pub-id-type="pmid">32621784</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>RF</given-names></name><name><surname>Breithaupt-Faloppa</surname><given-names>AC</given-names></name><name><surname>Matsubara</surname><given-names>BC</given-names></name><name><surname>Rodrigues</surname><given-names>G</given-names></name><name><surname>Sanches</surname><given-names>MP</given-names></name><name><surname>Armstrong-Jr</surname><given-names>R</given-names></name><etal/></person-group> <article-title>17<italic>&#x03B2;</italic>-estradiol protects against lung injuries after brain death in male rats</article-title>. <source>J Heart Lung Transplant</source>. (<year>2018 Nov</year>) <volume>37</volume>(<issue>11</issue>):<fpage>1381</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.healun.2018.06.015</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balligand</surname><given-names>JL</given-names></name><name><surname>Feron</surname><given-names>O</given-names></name><name><surname>Dessy</surname><given-names>C</given-names></name></person-group>. <article-title>eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues</article-title>. <source>Physiol Rev</source>. (<year>2009</year>) <volume>89</volume>(<issue>2</issue>):<fpage>481</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00042.2007</pub-id><pub-id pub-id-type="pmid">19342613</pub-id></citation></ref></ref-list>
</back>
</article>